Ana-Zeralda Canals Hamann

Senior Clinical Trial Supplies Manager Debiopharm

Main Conference - Day One

10:45 AM CASE STUDY I FROM TEMPERATURE TO FULL CONDITION MONITORING - A REVOLUTION IN SAFEGUARDING ADVANCED TARGETED DRUGS

The pharmaceutical industry thrives on precision and reliability. This session zeroes in on the vital role real-time tracking holds in strengthening the clinical supply chain. Participants will delve into creative plans and tech breakthroughs which equip companies to actively safeguard their clinical supply chain. From the production line to distribution and beyond, this checking in real-time ensures top-notch quality, secure, and efficient clinical supply chains.

Key Learnings:

  • Whole Supply Chain Visibility: Grasp how keeping tabs on things in real-time provides a full view of the clinical supply chain. This technique allows those involved to track pharmaceutical products at every move.
  • Risk Mitigation and Adherence: Discover how real-time monitoring systems help reduce risks by identifying potential problems early and dealing with them promptly. This increases adherence to set rules and quality controls.
  • Cutting Down on Lost Items and Wasted Drug: Keeping constant watch helps keep items from being lost or damaged.
  • Better Safety for Patients: Learn how constant monitoring affects patients’ safety. It makes sure IMPs is in optimal conditions, which ensures correct treatment conditionsand lowers the chance of errors.

Main Conference - Day Two

12:00 PM INTERACTIVE ROUNDTABLE DISCUSSION GROUPS I EXPANDING HORIZONS FOR CLINICAL TRIAL SUPPLY

INVESTIGATING NEW REGIONS & THERAPIES: SEIZING THE OPPORTUNITIES OF AN EXPANDING CLINICAL TRIAL SUPPLY ECOSYSTEM

 How does it work? Choose a 45-minute discussion on a pressing clinical trial supply topic. Interact with your peers, identifying contemporary challenges and novel approaches to confronting them. Each roundtable is led by a subject matter expert.

 Following the conclusion of the discussions, there will be a 30-minute feedback session, where the roundtable leaders will share the key findings that came out of their respective discussions.

The discussion groups are:

GROUP A - HOW CAN WE BREAK DOWN SILOED DECISION-MAKING IN CLINICAL TRIAL SUPPLY?

GROUP B - OVERCOMING THE SUPPLY CHAIN CHALLENGES IN EMERGING CLINICAL TRIAL REGIONS

GROUP C- INDUSTRY BEST PRACTICES AND EMERGING TECH FOR A GREENER FUTURE OF CLINICAL TRIALS

GROUP D - HOW DO WE STRENGTHEN OUR SUPPLY CHAINS IN A “VUCA” WORLD?

GROUP E - INDUSTRY BEST PRACTICES TRENDING & MITIGATING TEMPERATURE DEVIATIONS

GROUP F - IDENTIFYING & USING THE BEST INDUSTRY CLINICAL SUPPLY CHAIN METRICS



 



 

Check out the incredible speaker line-up to see who will be joining Ana-Zeralda.

Download The Latest Agenda